Xue-si Wu

A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure

Runlin Gao, Jian Zhang, Liuquan Cheng et al. · Journal of the American College of Cardiology · 2010 · 278 citations

Medicine, Cardiology, Pharmacotherapy +11

Neuregulin-1 preconditioning protects the heart against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.

Shan‐Juan Fang, Xue-si Wu, Zhihong Han et al. · PubMed · 2010 · 67 citations

Medicine, Biochemistry, Cardiology +14

Myocardial blood flow estimated by synchronous, multislice, high-speed computed tomography

Tao Wang, Xue-si Wu, Namsik Chung et al. · IEEE Transactions on Medical Imaging · 1989 · 56 citations

Medicine, Cardiology, Radiology +17

Neuregulin-1 suppresses cardiomyocyte apoptosis by activating PI3K/Akt and inhibiting mitochondrial permeability transition pore

Bingzhang Jie, Xiaoxia Zhang, Xue-si Wu et al. · Molecular and Cellular Biochemistry · 2012 · 52 citations

Life Sciences, Biochemistry, Cell Biology +14

Neuregulin‐1 promotes mitochondrial biogenesis, attenuates mitochondrial dysfunction, and prevents hypoxia/reoxygenation injury in neonatal cardiomyocytes

Xiao‐Xia Zhang, Xue-si Wu, Shuhua Mi et al. · Cell Biochemistry and Function · 2020 · 31 citations

Life Sciences, Cardiology, Physiology +17